Hoffmann, J. H. (2017) “Routine Laboratory Parameter Dynamics and Laboratory Adverse Events in Psoriasis Patients on Long-term Treatment with Adalimumab, Etanercept, and Ustekinumab”, Acta Dermato-Venereologica, 97(6), pp. 705–710. doi: 10.2340/00015555-2644.